Header Logo

Connection

Jaejin An to Female

This is a "connection" page, showing publications Jaejin An has written about Female.
Connection Strength

1.819
  1. Race, Ethnicity, and Language Concordance Between Patients and Physicians and Atrial Fibrillation DOAC Treatment. JAMA Netw Open. 2026 Sep 01; 9(9):e2629363.
    View in: PubMed
    Score: 0.085
  2. Cardiovascular and Kidney Events Associated with Visit-to-Visit Blood Pressure Variability among Young Adults with Hypertension. Am J Hypertens. 2026 Aug 01; 39(8):988-996.
    View in: PubMed
    Score: 0.084
  3. Sex Differences in Hypertension Diagnosis Among Young Adults in a US Integrated Health Care System. J Am Heart Assoc. 2026 08 04; 15(15):e042879.
    View in: PubMed
    Score: 0.084
  4. Trends in Initial Combination Antihypertensive Therapy in a US Health System. Am J Hypertens. 2026 Jun 01; 39(6):787-796.
    View in: PubMed
    Score: 0.083
  5. Validation of electronic health record-based International Society on Thrombosis and Haemostasis bleeding algorithms in a US health system. Res Pract Thromb Haemost. 2026 May; 10(4):106616.
    View in: PubMed
    Score: 0.083
  6. Cost-effectiveness of implementing a home blood pressure telemonitoring program. Am J Manag Care. 2026 Mar; 32(3):146-152.
    View in: PubMed
    Score: 0.082
  7. PREVENT Equation Performance in Asian and Native Hawaiian and Other Pacific Islander Groups. JAMA Netw Open. 2026 02 02; 9(2):e2556915.
    View in: PubMed
    Score: 0.081
  8. Factors Associated with Treatment Intensification for Uncontrolled Hypertension in a US Health System. J Gen Intern Med. 2026 05; 41(7):1881-1891.
    View in: PubMed
    Score: 0.081
  9. Follow-Up Lipid Testing and Statin Initiation Among Young Adults in a U.S. Health Care System. J Am Coll Cardiol. 2026 Mar 24; 87(11):1327-1339.
    View in: PubMed
    Score: 0.080
  10. Development and Validation of an Incident Hypertension Risk Prediction Model for Young Adults. J Am Heart Assoc. 2025 Jul 15; 14(14):e040769.
    View in: PubMed
    Score: 0.078
  11. Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10-Year Atherosclerotic Cardiovascular Risk Prediction. J Am Heart Assoc. 2025 Feb 18; 14(4):e039454.
    View in: PubMed
    Score: 0.076
  12. Blood Pressure Reduction and Changes in Antihypertensive Medication Use Among Patients With Hypertension Who Initiated Sodium-Glucose Cotransporter-2 Inhibitors. J Clin Hypertens (Greenwich). 2024 Nov; 26(11):1318-1321.
    View in: PubMed
    Score: 0.074
  13. Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes. BMJ Open Diabetes Res Care. 2021 01; 9(1).
    View in: PubMed
    Score: 0.057
  14. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System. J Am Heart Assoc. 2021 02 02; 10(3):e019669.
    View in: PubMed
    Score: 0.057
  15. Recurrent Atherosclerotic Cardiovascular Event Rates Differ Among Patients Meeting the Very High Risk Definition According to Age, Sex, Race/Ethnicity, and Socioeconomic Status. J Am Heart Assoc. 2020 12; 9(23):e017310.
    View in: PubMed
    Score: 0.057
  16. Treatment Patterns and Blood Pressure Control With Initiation of Combination Versus Monotherapy Antihypertensive Regimens. Hypertension. 2021 01; 77(1):103-113.
    View in: PubMed
    Score: 0.057
  17. Impact of pill burden on adherence to hepatitis C medication. Curr Med Res Opin. 2019 11; 35(11):1937-1944.
    View in: PubMed
    Score: 0.052
  18. Prevalence of comorbidities and their associations with health-related quality of life and healthcare expenditures in patients with rheumatoid arthritis. Clin Rheumatol. 2019 Oct; 38(10):2717-2726.
    View in: PubMed
    Score: 0.051
  19. Association between different types of comorbidity and disease burden in patients with diabetes. J Diabetes. 2019 Jan; 11(1):65-74.
    View in: PubMed
    Score: 0.048
  20. Adherence to the American Diabetes Association retinal screening guidelines for population with diabetes in the United States. Ophthalmic Epidemiol. 2018 06; 25(3):257-265.
    View in: PubMed
    Score: 0.047
  21. Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care System. J Manag Care Spec Pharm. 2017 Jun; 23(6):700-712.
    View in: PubMed
    Score: 0.045
  22. The Impact of Patient-Centered Medical Homes on Quality of Care and Medication Adherence in Patients with Diabetes Mellitus. J Manag Care Spec Pharm. 2016 Nov; 22(11):1272-1284.
    View in: PubMed
    Score: 0.043
  23. Cardiovascular Outcomes Associated with Lowering Low-density Lipoprotein Cholesterol in Rheumatoid Arthritis and Matched Nonrheumatoid Arthritis. J Rheumatol. 2016 11; 43(11):1989-1996.
    View in: PubMed
    Score: 0.042
  24. Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting. Arthritis Care Res (Hoboken). 2016 05; 68(5):629-37.
    View in: PubMed
    Score: 0.041
  25. Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice. J Am Heart Assoc. 2015 Jul 17; 4(7).
    View in: PubMed
    Score: 0.039
  26. Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension. Med Care. 2013 Oct; 51(10):879-87.
    View in: PubMed
    Score: 0.035
  27. Comparison of Healthcare Resource Utilization and Disease Outcomes in Adults Hospitalized with Human Metapneumovirus and Respiratory Syncytial Virus. J Infect Dis. 2026 Mar 17; 233(3):e651-e661.
    View in: PubMed
    Score: 0.021
  28. Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study. Diabetes Care. 2025 Oct 01; 48(10):1737-1743.
    View in: PubMed
    Score: 0.020
  29. Glucose-Lowering Medication Classes and Cardiovascular Outcomes in Patients With Type 2 Diabetes. JAMA Netw Open. 2025 10 01; 8(10):e2536100.
    View in: PubMed
    Score: 0.020
  30. PREVENT and PCE Models for Estimating ASCVD Risk Stratified by Statin Exposure. JAMA Netw Open. 2025 Sep 02; 8(9):e2532164.
    View in: PubMed
    Score: 0.020
  31. GLP-1RA comparative effectiveness against dementia onset relative to other antidiabetic medications in a large, multi-site cohort of patients with type 2 diabetes. Alzheimers Dement. 2025 Sep; 21(9):e70621.
    View in: PubMed
    Score: 0.020
  32. Blood Pressure Control Among Black and White Adults Following a Quality Improvement Program in a Large Integrated Health System. JAMA Netw Open. 2023 01 03; 6(1):e2249930.
    View in: PubMed
    Score: 0.016
  33. Comparison of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Bioprosthetic Heart Valves. Am J Cardiol. 2021 05 01; 146:22-28.
    View in: PubMed
    Score: 0.014
  34. Cost of Hospitalization Associated With Respiratory Syncytial Virus Infection Versus Influenza Infection in Hospitalized Older Adults. J Infect Dis. 2020 08 17; 222(6):962-966.
    View in: PubMed
    Score: 0.014
  35. Treatment discontinuation of oral hypoglycemic agents and healthcare utilization among patients with diabetes. J Diabetes Complications. 2016 Nov - Dec; 30(8):1443-1451.
    View in: PubMed
    Score: 0.011
  36. The impact of value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation. Value Health. 2010 Sep-Oct; 13(6):846-52.
    View in: PubMed
    Score: 0.007
  37. Clinical features of patients with a myocardial infarction during acute management of an ischemic stroke. Neurocrit Care. 2008; 9(3):332-7.
    View in: PubMed
    Score: 0.006
  38. The leukoaraiosis is more prevalent in the large artery atherosclerosis stroke subtype among Korean patients with ischemic stroke. BMC Neurol. 2008 Aug 07; 8:31.
    View in: PubMed
    Score: 0.006

© 2026 Kaiser Permanente

Your Privacy Choices